Mattson, C. L. et al. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb. Mortal. Wkly. Rep. 70, 202–207 (2021).

PubMed  PubMed Central  Google Scholar 

Gardner, E. A., McGrath, S. A., Dowling, D. & Bai, D. The opioid crisis: prevalence and markets of opioids. Forensic Sci. Rev. 34, 43–70 (2022).

CAS  PubMed  Google Scholar 

Drug Overdose Deaths- NIDA. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates.

CDC, National Center for Health Statistics, Office of Communication. U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020—But Are Still Up 15%. cdc.gov https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm.

Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819–823 (1996).

CAS  PubMed  Google Scholar 

James, A. & Williams, J. Basic opioid pharmacology—an update. Br. J. Pain. 14, 115–121 (2020).

PubMed  PubMed Central  Google Scholar 

Volkow, N. D. & Wargo, E. M. Overdose prevention through medical treatment of opioid use disorders. Ann. Intern Med. 169, 190 (2018).

PubMed  Google Scholar 

Volkow, N. D., Frieden, T. R., Hyde, P. S. & Cha, S. S. Medication-assisted therapies—tackling the opioid-overdose epidemic. N. Engl. J. Med. 370, 2063–2066 (2014).

PubMed  Google Scholar 

Dickson-Gomez, J. et al. “You’re Not Supposed to be on it Forever”: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst. Abus. 16, 117822182211038 (2022).

Google Scholar 

Madden, E. F., Prevedel, S., Light, T. & Sulzer, S. H. Intervention stigma toward medications for opioid use disorder: a systematic review. Subst. Use Misuse 56, 2181–2201 (2021).

PubMed  Google Scholar 

Larochelle, M. R. et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann. Intern. Med. 169, 137 (2018).

PubMed  PubMed Central  Google Scholar 

Sullivan, L. E. & Fiellin, D. A. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann. Intern. Med. 148, 662 (2008).

PubMed  PubMed Central  Google Scholar 

SAMHSA Medications for Opioid Use Disorder. https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP21-02-01-002.pdf.

Yamamoto, A. et al. Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Soc. Sci. Med. 242, 112585 (2019).

PubMed  PubMed Central  Google Scholar 

Bateman, J. T., Saunders, S. E. & Levitt, E. S. Understanding and countering opioid‐induced respiratory depression. Br. J. Pharmacol. bph.15580 https://doi.org/10.1111/bph.15580 (2021).

Eliza Wheeler, T., Stephen, J., Michael K. G., Peter J. D., Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morb Mortal Wkly Rep. 64, 631-635 (2015).

Volkow, N. D. & Collins, F. S. The role of science in addressing the opioid crisis. N. Engl. J. Med. 377, 391–394 (2017).

PubMed  Google Scholar 

Collins, F. S., Koroshetz, W. J. & Volkow, N. D. Helping to end addiction over the long-term: the research plan for the NIH HEAL initiative. JAMA 320, 129 (2018).

PubMed  PubMed Central  Google Scholar 

Raleigh, M. D., Accetturo, C. & Pravetoni, M. Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity. J. Pharm. Exp. Ther. 374, 392–403 (2020).

CAS  Google Scholar 

Kimishima, A., Olson, M. E. & Janda, K. D. Investigations into the efficacy of multi-component cocaine vaccines. Bioorg. Med. Chem. Lett. 28, 2779–2783 (2018).

CAS  PubMed  Google Scholar 

Stevens, M. W., Gunnell, M. G., Tawney, R. & Owens, S. M. Optimization of a methamphetamine conjugate vaccine for antibody production in mice. Int. Immunopharmacol. 35, 137–141 (2016).

CAS  PubMed  PubMed Central  Google Scholar 

Kosten, T. R. et al. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 140, 42–47 (2014).

CAS  PubMed  PubMed Central  Google Scholar 

Cornuz, J. et al. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One 3, e2547 (2008).

PubMed  PubMed Central  Google Scholar 

Hatsukami, D. K. et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin. Pharm. Ther. 89, 392–399 (2011).

CAS  Google Scholar 

Bonese, K. F., Wainer, B. H., Fitch, F. W., Rothberg, R. M. & Schuster, C. R. Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 252, 708–710 (1974).

CAS  PubMed  Google Scholar 

Pravetoni, M. & Comer, S. D. Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology 158, 107662 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Alving, C. R., Matyas, G. R., Torres, O., Jalah, R. & Beck, Z. Adjuvants for vaccines to drugs of abuse and addiction. Vaccine 32, 5382–5389 (2014).

CAS  PubMed  PubMed Central  Google Scholar 

Shen, X. Y., Orson, F. M. & Kosten, T. R. Vaccines against drug abuse. Clin. Pharm. Ther. 91, 60–70 (2012).

CAS  Google Scholar 

Kimishima, A., Wenthur, C. J., Zhou, B. & Janda, K. D. An advance in prescription opioid vaccines: overdose mortality reduction and extraordinary alteration of drug half-life. ACS Chem. Biol. 12, 36–40 (2017).

CAS  PubMed  Google Scholar 

Hamid, F. A. et al. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine 40, 3244–3252 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

Bremer, P. T. et al. Development of a clinically viable heroin vaccine. J. Am. Chem. Soc. 139, 8601–8611 (2017).

CAS  PubMed  PubMed Central  Google Scholar 

Belz, T. F. et al. Enhancement of a heroin vaccine through hapten deuteration. J. Am. Chem. Soc. 142, 13294–13298 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Hwang, C. S. et al. Heroin vaccine: using titer, affinity, and antinociception as metrics when examining sex and strain differences. Vaccine 37, 4155–4163 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Brisse, M., Vrba, S. M., Kirk, N., Liang, Y. & Ly, H. Emerging concepts and technologies in vaccine development. Front. Immunol. 11, 583077 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Baehr, C. et al. Preclinical efficacy and selectivity of vaccines targeting fentanyl, alfentanil, sufentanil, and acetylfentanyl in rats. ACS Omega 7, 16584–16592 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

Stone, A. E. et al. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ Vaccin. 6, 69 (2021).

CAS  Google Scholar 

Crouse, B. et al. Efficacy and selectivity of monovalent and bivalent vaccination strategies to protect against exposure to carfentanil, fentanyl, and their mixtures in rats. ACS Pharmacol. Transl. Sci. 5, 331–343 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

Frietze, K. M., Peabody, D. S. & Chackerian, B. Engineering virus-like particles as vaccine platforms. Curr. Opin. Virol. 18, 44–49 (2016).

CAS  PubMed  PubMed Central  Google Scholar 

Chackerian, B., Lowy, D. R. & Schiller, J. T. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Investig. 108, 415–423 (2001).

CAS  PubMed  PubMed Central  Google Scholar 

Collar, A. L., Linville, A. C., Core, S. B. & Frietze, K. M. Epitope-based vaccines against the chlamydia trachomatis major outer membrane protein variable domain 4 elicit protection in mice. Vaccines 10, 875 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

Jelínková, L. et al. A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model. NPJ Vaccin. 7, 34 (2022).

Google Scholar 

Warner, N. L. & Frietze, K. M. Development of bacteriophage virus-like particle vaccines displaying conserved epitopes of dengue virus non-structural protein 1. Vaccines 9, 726 (2021).

CAS  PubMed